摘要:
An image forming apparatus of non-contact developing method using two-component developer material which is capable of obtaining a clear image free from fogging, ghost and toner contamination. The image forming apparatus has at least one developing unit which includes a developing roll and a magnetic roll, the developing unit develops an electrostatic latent image on a photosensitive body with a toner thin layer formed on the surface of a developing roll wherein a toner thin layer forming region on the developing roll is smaller than a magnetic brush forming region on the magnetic roll. A high resistivity region is adjacent each end of the toner thin layer forming region on the developing roll. A control device controls a developer material replenishment and controls the biasing to the developing roll and magnetic roll.
摘要:
When image formation is performed by an apparatus comprising: a magnetic roll for generating a magnetic brush by carrier having toner adhering triboelectrically thereto, a developer roll on the surface of which a thin layer of the toner supplied by the magnetic brush is formed, and a photoreceptor onto which the toner of thin layer jumps selectively in accordance with the latent image thereon; positively chargeable toner of which charge amount is controlled in 5˜20 &mgr;C/g is used, the surface potential of the photoreceptor is set to a range above 0 to 250 V, and the after exposure potential which is the potential right after the photoreceptor is exposed is in a range of 0˜ to 100 V.
摘要:
The present invention relates to an image forming process and an image forming apparatus, which have a refresh means which refreshes the developing sleeve by allowing the toner on the developing sleeve to jump toward the photoreceptor drum when transfer to recording medium is not done. Refresh is performed by applying an AC bias between the photoreceptor drum and the developing sleeve. The number of dots of latent image corresponding to actual image pattern is counted and the ratio of this number of dots to the number of dots corresponding to full black original image is defined as print rate, and cumulative average print rate is calculated each time when a page or a predetermined number of pages is printed. When the average print rate falls short of proper print rate, refresh is performed. It is suitable to set several proper print rate, and the duration of application of the AC bias is varied according to the average print rate. It is also effective to apply AC bias for refresh higher in effective voltage than applied for developing. It is also effective to prevent “fog” by applying transfer reverse bias to transfer part until the toner on the photoreceptor passes the transfer part and transfer positive bias after cleaning of the toner on the photoreceptor is finished. Generally, when an image forming apparatus is used for an extended period of time or when low print rate original image is copied in large quantity, deterioration such as reduction in print density and “fog” is liable to occur. According to the present invention, even if images of low print rate is copied in large quantity, deterioration does not occur.
摘要:
A process for producing an image comprising the steps of: electrically charging a photoreceptor under dark; forming a latent image on the photoreceptor through selective imagewise exposure to light; and developing the latent image with a two-component developer comprising a carrier and a toner, the photoreceptor comprising a conductive substrate having thereon a photoconductive layer comprising amorphous silicon having a thickness of 25 .mu.m or less, the carrier is a magnetic material carrier comprising particles of a magnetic material having an average particle diameter of from 35 to 60 .mu.m, where the content of particles having a diameter of 44 .mu.m or more is 35% by weight or more. A two-component developer comprising a carrier and a toner, the carrier comprising particles of a magnetic material having an average particle diameter of from 35 to 60 .mu.m, where the content of particles having a diameter of 44 .mu.m or more is 35% by weight or more.
摘要:
[PROBLEMS] To provide a polypeptide having a novel structure and showing an activity of inhibiting angiogenesis or an activity of inhibiting osteoclastogenesis, and to provide a recombinant protein by constructing a method of purifying the above protein. To provide an ingredient useful in designing remedies for tendinitis, rheumatoid arthritis, arthritis deformans, malignant tumor, etc.[MEANS FOR SOLVING PROBLEMS] A novel soluble polypeptide protein.
摘要:
The present invention relates to a screening method for a compound and includes a step of detecting binding between a vitamin D receptor and CDP. A novel method enabling screening in vitro of a compound having strong bone forming action and low side effects, a compound participating in osteoblast differentiation and selected by the method of screening, a therapeutic agent containing the compound for diseases intervening in the increase in vitamin D-mediated transcriptional activity by a complex of a vitamin D receptor and CDP, and a kit for performing the screening method are provided.
摘要:
[Problems] To provide a polypeptide having a novel structure and showing an activity of inhibiting angiogenesis or an activity of inhibiting osteoclastogenesis, and to provide a recombinant protein by constructing a method of purifying the above protein. To provide an ingredient useful in designing remedies for tendinitis, rheumatoid arthritis, arthritis deformans, malignant tumor, etc.[Means for Solving Problems] A novel soluble polypeptide protein.
摘要:
A developing apparatus employing a three-pole stationary magnetic roller for use with a uni-component magnetic developer or toner. The apparatus includes a rotational sleeve which accommodates the stationary roller, a mixer disposed in a toner vessel for stirring the toner, and a toner layer thickness regulator disposed upstream in the sleeve rotation direction from the developing position at which the image on a photo-sensitive drum is developed. The magnetic roller has a developing pole located near the developing position, a blade-facing pole facing the toner layer thickness regulator, and a shield pole located downstream in the sleeve rotation direction from the developing position, where the blade-facing pole and the shield pole are of the opposite polarity to the developing pole. The blade-facing pole and the shield pole generate a repulsive magnetic field therebetween, where the toner that has been stirred in the vessel comes in contact with the sleeve.
摘要:
To provide a novel vitamin D3 derivative useful as a therapeutic agent for osteoporosis.Provided is a vitamin D3 derivative represented by the following formula (1) or a medicinally acceptable solvate thereof: wherein R1 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, an alkylcarbonyloxyalkyl group with each alkyl having 1 to 6 carbon atoms, or an arylcarbonyloxyalkyl group with the aryl having 6 to 10 carbon atoms and the alkyl having 1 to 6 carbon atoms; R2 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms or, together with the other R2 and the carbon atom to which they are bound to, may form a cyclic alkyl group having 3 to 6 carbon atoms; R3 represents an alkyl group having 1 to 6 carbon atoms or, together with the other R3 and the carbon atom to which they are bound to, may form a cyclic alkyl group having 3 to 6 carbon atoms; X represents an oxygen atom or a methylene group; and n represents an integer of 1 or 2.
摘要翻译:提供可用作骨质疏松症治疗剂的新型维生素D3衍生物。 本发明提供由下式(1)表示的维生素D3衍生物或其药学上可接受的溶剂合物:其中,R1表示氢原子,碳原子数1〜6的烷基,碳原子数1〜6的烷基的烷基羰氧基烷基 或芳基具有6至10个碳原子的芳基羰氧基烷基和具有1至6个碳原子的烷基; R 2表示氢原子或碳原子数1〜6的烷基,或者与其它的R 2和与它们相连的碳原子一起形成可以形成碳原子数为3〜6的环状烷基。 R 3表示碳原子数为1〜6的烷基,或者与另外的R 3及与它们相连的碳原子一起形成碳原子数为3〜6的环状烷基。 X表示氧原子或亚甲基; n表示1或2的整数。
摘要:
[PROBLEMS] To provide a polypeptide having a novel structure and showing an activity of inhibiting angiogenesis or an activity of inhibiting osteoclastogenesis, and to provide a recombinant protein by constructing a method of purifying the above protein. To provide an ingredient useful in designing remedies for tendinitis, rheumatoid arthritis, arthritis deformans, malignant tumor, etc.[MEANS FOR SOLVING PROBLEMS] A novel soluble polypeptide protein.